BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2955818)

  • 1. Photoradiation models for the clinical ex vivo treatment of autologous bone marrow grafts.
    Atzpodien J; Gulati SC; Strife A; Clarkson BD
    Blood; 1987 Aug; 70(2):484-9. PubMed ID: 2955818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photoradiation methods for purging autologous bone marrow grafts.
    Gulati S; Atzpodien J; Lemoli RM; Shimazaki C; Clarkson B
    Prog Clin Biol Res; 1990; 333():87-102. PubMed ID: 2137934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dye-mediated photolysis is capable of eliminating drug-resistant (MDR+) tumor cells.
    Lemoli RM; Igarashi T; Knizewski M; Acaba L; Richter A; Jain A; Mitchell D; Levy J; Gulati SC
    Blood; 1993 Feb; 81(3):793-800. PubMed ID: 8427970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newer options for treating drug-resistant (MDR+) cancer cells using photoradiation therapy.
    Gulati SC; Lemoli RM; Igarashi T; Atzpodien J
    Leuk Lymphoma; 1994 Feb; 12(5-6):427-33. PubMed ID: 8180606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro cytotoxicity of VP-16-213 and nitrogen mustard: agonistic on tumor cells but not on normal human bone marrow progenitors.
    Lemoli RM; Gulati SC
    Exp Hematol; 1990 Oct; 18(9):1008-12. PubMed ID: 2397748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of clonogenic tumor cells from HL-60, Daudi, and U-937 cell lines by laser photoradiation therapy: implications for autologous bone marrow purging.
    Gulliya KS; Pervaiz S
    Blood; 1989 Mar; 73(4):1059-65. PubMed ID: 2920207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Merocyanine 540 mediated photolysis of normal bone marrow, committed hemopoietic progenitors and neoplastic cells. implications for bone marrow purging.
    Lydaki E; Dimitriou H; Papazoglou T; Liu WQ; Kalmanti M
    Leuk Res; 1997 Jul; 21(7):641-50. PubMed ID: 9301685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the cytotoxic effects of merocyanine-540 on leukemic cells and normal human bone marrow.
    Atzpodien J; Gulati SC; Clarkson BD
    Cancer Res; 1986 Oct; 46(10):4892-5. PubMed ID: 3756850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of leukemic cells by laser photodynamic therapy.
    Gulliya KS; Fay JW; Dowben RM; Berkholder S; Matthews JL
    Cancer Chemother Pharmacol; 1988; 22(3):211-4. PubMed ID: 3165726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CFU-GM content of bone marrow graft correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged bone marrow.
    Rowley SD; Zuehlsdorf M; Braine HG; Colvin OM; Davis J; Jones RJ; Saral R; Sensenbrenner LL; Yeager A; Santos GW
    Blood; 1987 Jul; 70(1):271-5. PubMed ID: 3297203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different repopulation kinetics of erythroid (BFU-E), myeloid (CFU-GM) and T lymphocyte (TL-CFU) progenitor cells after autologous and allogeneic bone marrow transplantation.
    Vellenga E; Sizoo W; Hagenbeek A; Löwenberg B
    Br J Haematol; 1987 Feb; 65(2):137-42. PubMed ID: 3548797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination.
    Lemoli RM; Gasparetto C; Scheinberg DA; Moore MA; Clarkson BD; Gulati SC
    Blood; 1991 Apr; 77(8):1829-36. PubMed ID: 2015406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined use of growth factors to stimulate the proliferation of hematopoietic progenitor cells after autologous bone marrow transplantation for lymphoma patients.
    Lemoli RM; Fortuna A; Fogli M; Rosti G; Gherlinzoni F; Visani G; Catani L; Gozzetti A; Tura S
    Acta Haematol; 1996; 95(3-4):164-70. PubMed ID: 8677737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.
    Wisniewski D; Strife A; Arlin Z; Knowles R; Lambek C; Gulati S; McHendry B; McKenzie S; Clarkson B
    Leukemia; 1989 Jun; 3(6):446-52. PubMed ID: 2657231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Purge of malignant cells from bone marrow by hematoporphyrin derivatives and light exposure in vitro].
    Xu CX; Lin L; Huang YY; Liu HY; Wang XR; Wang YX; Zhang BL; Li XR; Hou YH
    Zhongguo Yao Li Xue Bao; 1990 Jan; 11(1):72-5. PubMed ID: 2144939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD33 monoclonal antibody and etoposide/cytosine arabinoside combinations for the ex vivo purification of bone marrow in acute nonlymphocytic leukemia.
    Stiff PJ; Schulz WC; Bishop M; Marks L
    Blood; 1991 Jan; 77(2):355-62. PubMed ID: 1985700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemia.
    Rowley SD; Jones RJ; Piantadosi S; Braine HG; Colvin OM; Davis J; Saral R; Sharkis S; Wingard J; Yeager AM
    Blood; 1989 Jul; 74(1):501-6. PubMed ID: 2665843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.